Nicholas Gross, MS

Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From an Open-Label Extension Study

BACKGROUND: In the 12-week ARM-TD and AIM-TD studies of patients with tardive dyskinesia (TD), the percentage of patients achieving ≥50% and ≥70% responses (i.e. reductions from baseline ...

Hubert Fernandez , MD;

Hadas Barkay , PhD;

Juha-Matti Savola , MD, PhD;

Nicholas Gross , MS;

Stewart Factor , DO;

Robert G. Hauser , MD, MBA, PhD;

Joohi Jimenez-Shahed , MD;

Karen Anderson , MD;

11/22/2019

Featured CME

The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.

Upcoming Events

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

May 28 ⁠–⁠ May 31

See Full Calendar

Nicholas Gross, MS

Featured CME

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products